{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-23-000994","form_type":"8-K","ticker":"CVS","cik":"0000064803","company_name":"CVS HEALTH Corp","filed_at":"2023-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.745407+00:00","generated_at":"2026-06-09T23:40:47.059424+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CVS CFO Shawn Guertin takes leave; Tom Cowhey named interim CFO; Mike Pykosz interim Health Svcs Pres","bullets":["Guertin's leave effective immediately for unforeseen family medical reasons; Cowhey (SVP Corporate Finance) appointed interim CFO.","Mike Pykosz, CEO of Oak Street Health, named interim President of Health Services, assuming Guertin's dual role.","FY2023 GAAP EPS guidance reaffirmed at $6.53-$6.75; Adjusted EPS reaffirmed at $8.50-$8.70.","Q3 earnings call remains Nov 1, 2023; Investor Day remains Dec 5, 2023, as previously scheduled."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-23-000994","json":"https://secwatch.observer/filing/0000947871-23-000994.json","markdown":"https://secwatch.observer/filing/0000947871-23-000994.md","text":"https://secwatch.observer/filing/0000947871-23-000994.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/0000947871-23-000994-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/ss2584510_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T23:40:47.059424+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05e06306e1","claim":"Shawn M. Guertin departed as Executive Vice President and Chief Financial Officer at CVS HEALTH Corp.","evidence_excerpt":"Effective October 13, 2023, Shawn M. Guertin, the Executive Vice President and Chief Financial Officer of CVS Health Corporation (“CVS Health,” the “Company,” “we” or “our”), has begun a personal leave of absence for unforeseen family medical reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/0000947871-23-000994-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"began a personal leave of absence"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"8057405486","claim":"Thomas F. Cowhey was appointed as Interim Chief Financial Officer at CVS HEALTH Corp.","evidence_excerpt":"Appointment of Interim Chief Financial Officer In connection with Mr. Guertin’s leave, the Company’s Board of Directors appointed Thomas F. Cowhey, Senior Vice President, Corporate Finance, to serve as the Company’s Interim Chief Financial Officer, effective October 13, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/64803/000094787123000994/0000947871-23-000994-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}